67 related articles for article (PubMed ID: 17613337)
1. Graves' quality of life.
Terwee CB; Wiersinga WM
Ophthalmology; 2007 Jul; 114(7):1416-7; author reply 1417-8. PubMed ID: 17613337
[No Abstract] [Full Text] [Related]
2. Evaluation of the National Eye Institute visual function questionnaire in Graves' ophthalmopathy.
Bradley EA; Sloan JA; Novotny PJ; Garrity JA; Woog JJ; West SK
Ophthalmology; 2006 Aug; 113(8):1450-4. PubMed ID: 16769116
[TBL] [Abstract][Full Text] [Related]
3. Critical issues on Graves' ophthalmopathy.
Rocchi R
MLO Med Lab Obs; 2006 May; 38(5):10-2, 14-5; quiz 16-7. PubMed ID: 16761864
[No Abstract] [Full Text] [Related]
4. Special issues for building computerized-adaptive tests for measuring patient-reported outcomes: the National Institute of Health's investment in new technology.
Reeve BB
Med Care; 2006 Nov; 44(11 Suppl 3):S198-204. PubMed ID: 17060828
[No Abstract] [Full Text] [Related]
5. Prevention of graves' orbitopathy: early diagnosis of thyroid-associated orbitopathy in Graves' disease.
Mourits MP
Orbit; 2008; 27(6):399-400. PubMed ID: 19085291
[No Abstract] [Full Text] [Related]
6. Increased retinal blood flow in patients with active Graves' ophthalmopathy.
Perri P; Campa C; Costagliola C; Incorvaia C; D'Angelo S; Sebastiani A
Curr Eye Res; 2007 Nov; 32(11):985-90. PubMed ID: 18027174
[TBL] [Abstract][Full Text] [Related]
7. Outcome of orbital decompression for disfiguring proptosis in patients with Graves' orbitopathy using various surgical procedures.
; Mourits MP; Bijl H; Altea MA; Baldeschi L; Boboridis K; CurrĂ² N; Dickinson AJ; Eckstein A; Freidel M; Guastella C; Kahaly GJ; Kalmann R; Krassas GE; Lane CM; Lareida J; Marcocci C; Marino M; Nardi M; Mohr Ch; Neoh C; Pinchera A; Orgiazzi J; Pitz S; Saeed P; Salvi M; Sellari-Franceschini S; Stahl M; von Arx G; Wiersinga WM
Br J Ophthalmol; 2009 Nov; 93(11):1518-23. PubMed ID: 19028743
[TBL] [Abstract][Full Text] [Related]
8. Association of CTLA-4 gene polymorphism with Graves' disease and ophthalmopathy in Iranian patients.
Esteghamati A; Khalilzadeh O; Mobarra Z; Anvari M; Tahvildari M; Amiri HM; Rashidi A; Solgi G; Parivar K; Nikbin B; Amirzargar A
Eur J Intern Med; 2009 Jul; 20(4):424-8. PubMed ID: 19524188
[TBL] [Abstract][Full Text] [Related]
9. Response to Cella et al, May 2006--supplement 1 Medical Care.
Valderas JM; Alonso J
Med Care; 2007 Oct; 45(10):1008; author reply 1008. PubMed ID: 17891001
[No Abstract] [Full Text] [Related]
10. Evaluation of minimum clinically meaningful changes in scores on the National Eye Institute Visual Function Questionnaire (NEI-VFQ) SST Report Number 19.
Submacular Surgery Trials Research Group
Ophthalmic Epidemiol; 2007; 14(4):205-15. PubMed ID: 17896299
[TBL] [Abstract][Full Text] [Related]
11. Predicting perceived quality of life scores from the National Eye Institute 25-item Visual Function Questionnaire.
La Grow SJ
Optom Vis Sci; 2007 Aug; 84(8):785-8. PubMed ID: 17700341
[TBL] [Abstract][Full Text] [Related]
12. A new era in surgical research: getting back to the patient.
Kent KC; Gelijns AC
Surgery; 2009 Jun; 145(6):579-81. PubMed ID: 19486754
[No Abstract] [Full Text] [Related]
13. Re: "Associations Between Thyroid Eye Disease and Glaucoma Among Those Enrolled in the National Institutes of Health All of Us Research Program".
Sidhu AS; Walker CEL; Al Yassin A; Xiradis N; Tweedie PJ; Kim D; Wong ELS; Lee MK; Tsoi AT; Fu MY; Ouyang MH; Gunasegaram J; Fatima A; Borchert G; Nguyen I; Agar A; Francis IC
Ophthalmic Plast Reconstr Surg; 2024 May-Jun 01; 40(3):356. PubMed ID: 38215458
[No Abstract] [Full Text] [Related]
14. Peripheral blood T lymphocyte sensitisation against calsequestrin and flavoprotein in patients with Graves' ophthalmopathy.
Nguyen B; Gopinath B; Tani J; Wescombe L; Wall JR
Autoimmunity; 2008 Aug; 41(5):372-6. PubMed ID: 18568642
[TBL] [Abstract][Full Text] [Related]
15. The role of genetics in Graves' disease and thyroid orbitopathy.
Kim N; Hatton MP
Semin Ophthalmol; 2008; 23(1):67-72. PubMed ID: 18214794
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic orbital decompression for Graves' ophthalmopathy.
Tang IP; Prepageran N; Shashinder S
Med J Malaysia; 2008 Mar; 63(1):67-8. PubMed ID: 18935740
[TBL] [Abstract][Full Text] [Related]
17. The pediatric quality of life inventory: measuring pediatric health-related quality of life from the perspective of children and their parents.
Varni JW; Limbers CA
Pediatr Clin North Am; 2009 Aug; 56(4):843-63. PubMed ID: 19660631
[TBL] [Abstract][Full Text] [Related]
18. Associations Between Thyroid Eye Disease and Glaucoma Among Those Enrolled in the National Institutes of Health All of Us Research Program: Corrigendum.
Ophthalmic Plast Reconstr Surg; 2023 Jul-Aug 01; 39(4):405. PubMed ID: 37413687
[No Abstract] [Full Text] [Related]
19. Late reactivation of thyroid associated ophthalmopathy causing optic neuropathy.
Bunting H; Creten O; Muhtaseb M; Shuttleworth G
Postgrad Med J; 2008 Jul; 84(993):388-90. PubMed ID: 18716022
[TBL] [Abstract][Full Text] [Related]
20. [Management of Graves' orbitopathy: evidence-based recommendations].
Ponto KA; Pitz S; Mann WJ; Weber MM; Pfeiffer N; Kahaly GJ
Dtsch Med Wochenschr; 2009 Dec; 134(49):2521-4. PubMed ID: 19941237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]